Vijaykumar Chennupati
University of Lausanne
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Vijaykumar Chennupati.
Journal of Experimental Medicine | 2016
Daniel T. Utzschneider; Francesca Alfei; Patrick Roelli; David Barras; Vijaykumar Chennupati; Stephanie Darbre; Mauro Delorenzi; Daniel D. Pinschewer; Dietmar Zehn
Using recombinant antigen variant-expressing chronic LCMV strains, Zehn and colleagues showed that amount rather than antigen strength is a key determinant of inducing a chronic infection phenotype in T cells.
Journal of Immunology | 2014
Caroline Boudousquié; Maxime Danilo; Laurène Pousse; Beena Jeevan-Raj; Georgi S. Angelov; Vijaykumar Chennupati; Dietmar Zehn; Werner Held
Protection against reinfection is mediated by Ag-specific memory CD8 T cells, which display stem cell–like function. Because canonical Wnt (Wingless/Int1) signals critically regulate renewal versus differentiation of adult stem cells, we evaluated Wnt signal transduction in CD8 T cells during an immune response to acute infection with lymphocytic choriomeningitis virus. Whereas naive CD8 T cells efficiently transduced Wnt signals, at the peak of the primary response to infection only a fraction of effector T cells retained signal transduction and the majority displayed strongly reduced Wnt activity. Reduced Wnt signaling was in part due to the downregulation of Tcf-1, one of the nuclear effectors of the pathway, and coincided with progress toward terminal differentiation. However, the correlation between low and high Wnt levels with short-lived and memory precursor effector cells, respectively, was incomplete. Adoptive transfer studies showed that low and high Wnt signaling did not influence cell survival but that Wnt high effectors yielded memory cells with enhanced proliferative potential and stronger protective capacity. Likewise, following adoptive transfer and rechallenge, memory cells with high Wnt levels displayed increased recall expansion, compared with memory cells with low Wnt signaling, which were preferentially effector-like memory cells, including tissue-resident memory cells. Thus, canonical Wnt signaling identifies CD8 T cells with enhanced proliferative potential in part independent of commonly used cell surface markers to discriminate effector and memory T cell subpopulations. Interventions that maintain Wnt signaling may thus improve the formation of functional CD8 T cell memory during vaccination.
Cell Reports | 2016
Susanne G. Oberle; Layane Hanna-El-Daher; Vijaykumar Chennupati; Sarah Enouz; Stefanie Scherer; Martin Prlic; Dietmar Zehn
Summary Many infections are caused by pathogens that are similar, but not identical, to previously encountered viruses, bacteria, or vaccines. In such re-infections, pathogens introduce known antigens, which are recognized by memory T cells and new antigens that activate naive T cells. How preexisting memory T cells impact the repertoire of T cells responding to new antigens is still largely unknown. We demonstrate that even a minimum epitope overlap between infections strongly increases the activation threshold and narrows the diversity of T cells recruited in response to new antigens. Thus, minimal cross-reactivity between infections can significantly impact the outcome of a subsequent immune response. Interestingly, we found that non-transferrable memory T cells are most effective in raising the activation threshold. Our findings have implications for designing vaccines and suggest that vaccines meant to target low-affinity T cells are less effective when they contain a strong CD8 T cell epitope that has previously been encountered.
Cell Reports | 2017
Beena Jeevan-Raj; Jasmine Gehrig; Mélanie Charmoy; Vijaykumar Chennupati; Camille Grandclément; Paolo Angelino; Mauro Delorenzi; Werner Held
The transcription factor Tcf1 is essential for the development of natural killer (NK) cells. However, its precise role has not been clarified. Our combined analysis of Tcf1-deficient and transgenic mice indicated that Tcf1 guides NK cells through three stages of development. Tcf1 expression directed bone marrow progenitors toward the NK cell lineage and ensured the survival of NK-committed cells, and its downregulation was needed for terminal maturation. Impaired survival of NK-committed cells was due to excessive expression of granzyme B (GzmB) and other granzyme family members, which induced NK cell self-destruction during maturation and following activation with cytokines or target cells. Mechanistically, Tcf1 binding reduced the activity of a Gzmb-associated regulatory element, and this accounted for the reduced Gzmb expression in Tcf1-expressing NK cells. These data identify an unexpected requirement to limit the expression of cytotoxic effector molecules for the normal expansion and function of NK cells.
Journal of Clinical Investigation | 2018
Vijaykumar Chennupati; Diogo Veiga; Kendle M. Maslowski; Nicola Andina; Aubry Tardivel; Eric Chi-Wang Yu; Martina Stilinovic; Cedric Simillion; Michel A. Duchosal; Manfredo Quadroni; Irene Roberts; Vijay G. Sankaran; H. Robson MacDonald; Nicolas Fasel; Anne Angelillo-Scherrer; Pascal Schneider; Trang Hoang; Ramanjaneyulu Allam
Ribosomal proteins (RP) regulate specific gene expression by selectively translating subsets of mRNAs. Indeed, in Diamond-Blackfan anemia and 5q– syndrome, mutations in RP genes lead to a specific defect in erythroid gene translation and cause anemia. Little is known about the molecular mechanisms of selective mRNA translation and involvement of ribosomal-associated factors in this process. Ribonuclease inhibitor 1 (RNH1) is a ubiquitously expressed protein that binds to and inhibits pancreatic-type ribonucleases. Here, we report that RNH1 binds to ribosomes and regulates erythropoiesis by controlling translation of the erythroid transcription factor GATA1. Rnh1-deficient mice die between embryonic days E8.5 and E10 due to impaired production of mature erythroid cells from progenitor cells. In Rnh1-deficient embryos, mRNA levels of Gata1 are normal, but GATA1 protein levels are decreased. At the molecular level, we found that RNH1 binds to the 40S subunit of ribosomes and facilitates polysome formation on Gata1 mRNA to confer transcript-specific translation. Further, RNH1 knockdown in human CD34+ progenitor cells decreased erythroid differentiation without affecting myelopoiesis. Our results reveal an unsuspected role for RNH1 in the control of GATA1 mRNA translation and erythropoiesis.
Journal of Immunology | 2016
Vijaykumar Chennupati; Ute Koch; Manuel Coutaz; Leonardo Scarpellino; Fabienne Tacchini-Cottier; Sanjiv A. Luther; Freddy Radtke; Dietmar Zehn; H. Robson MacDonald
Although Notch signaling plays important roles in lineage commitment and differentiation of multiple cell types including conventional T cells, nothing is currently known concerning Notch function in innate-like T cells. We have found that the homeostasis of several well-characterized populations of innate-like T cells including invariant NKT cells (iNKT), CD8ααTCRαβ small intestinal intraepithelial lymphocytes, and innate memory phenotype CD8 T cells is controlled by Notch. Notch selectively regulates hepatic iNKT cell survival via tissue-restricted control of B cell lymphoma 2 and IL-7Rα expression. More generally, Notch regulation of innate-like T cell homeostasis involves both cell-intrinsic and -extrinsic mechanisms and relies upon context-dependent interactions with Notch ligand-expressing fibroblastic stromal cells. Collectively, using conditional ablation of Notch receptors on peripheral T cells or Notch ligands on putative fibroblastic stromal cells, we show that Notch signaling is indispensable for the homeostasis of three tissue-restricted populations of innate-like T cells: hepatic iNKT, CD8ααTCRαβ small intestinal intraepithelial lymphocytes, and innate memory phenotype CD8 T cells, thus supporting a generalized role for Notch in innate T cell homeostasis.
Immunity | 2016
Daniel T. Utzschneider; Mélanie Charmoy; Vijaykumar Chennupati; Laurène Pousse; Daniela Pais Ferreira; Sandra Calderon-Copete; Maxime Danilo; Francesca Alfei; Maike Hofmann; Dominik Wieland; Sylvain Pradervand; Robert Thimme; Dietmar Zehn; Werner Held
Experimental Hematology | 2017
Ramanjaneyulu Allam; Vijaykumar Chennupati; Diogo Veiga; Kendle M. Maslowski; Aubry Tardivel; Nicola Andina; Eric Chi-Wang Yu; Martina Stilinovic; Cedric Simillion; Michel A. Duchosal; Manfredo Quadroni; Irene Roberts; Vijay G. Sankaran; H. Robson MacDonald; Nicolas Fasel; Anne Angelillo-Scherrer; Pascal Schneider; Trang Hoang
Cell Reports | 2018
Maxime Danilo; Vijaykumar Chennupati; Joana Gomes Silva; Stefanie Siegert; Werner Held
Immunity | 2017
Vijaykumar Chennupati; Werner Held